Clinical Trial Update: Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the analgesic and antinociceptive effects of milnacipran in fibromyalgia. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia Syndrome

Drugs mentioned

• Milnacipran (milnacipran)

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Fibromyalgia Syndrome | Phase 2 | Status: COMPLETED